Welcome to our dedicated page for Amedisys news (Ticker: AMED), a resource for investors and traders seeking the latest updates and insights on Amedisys stock.
Amedisys Inc (NASDAQ: AMED) provides essential home healthcare, hospice, and high-acuity care services across the United States. This news hub offers investors and industry professionals direct access to verified corporate announcements and financial updates from the home healthcare leader.
Track material developments including quarterly earnings reports, regulatory filings, clinical program expansions, and strategic partnerships. Our curated collection features official press releases, SEC disclosures, and market-moving updates - all organized chronologically for efficient research.
Key content categories include financial performance updates, Medicare/Medicaid compliance changes, care center acquisitions, leadership appointments, and clinical quality initiatives. Bookmark this page for real-time access to operational milestones that shape AMED's position in the $300B home healthcare market.
For stakeholders monitoring the shift toward value-based care models, this resource simplifies tracking of Amedisys' evolving service offerings and regulatory compliance status. Visit regularly to stay informed about critical developments affecting one of America's largest home health providers.
Amedisys (NASDAQ: AMED) announces a collaboration with Option Care Health (NASDAQ: OPCH) to provide COVID antibody infusion therapy in long-term care facilities. The pilot program, starting in Indianapolis and Valparaiso, Indiana, aims to enhance access to vital therapies for high-risk COVID-19 patients. Amedisys will manage care coordination, while Option Care Health will oversee clinical pharmacy operations and distribute Bamlanivimab. This partnership reflects both companies' commitment to addressing critical healthcare challenges during the pandemic.
Amedisys, a top home health and hospice provider, announced that CEO Paul B. Kusserow will present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 3:40 p.m. ET. Investors can access the live webcast via the company’s website. Amedisys delivers personalized healthcare at home, serving over 415,000 patients annually through a network of 516 care centers across 39 states and D.C. With a strong focus on patient-centered care, it partners with more than 2,600 hospitals and 67,000 physicians nationwide.
Amedisys, Inc. (NASDAQ: AMED) has authorized a stock repurchase program allowing the company to buy back up to $100 million of its common stock by December 31, 2021. CFO Scott Ginn noted the decision reflects the company's strong cash flow and low leverage, emphasizing that share buybacks will be part of their capital deployment strategy, alongside priority on acquisitions in Home Health and Hospice. Repurchases may occur through various methods, depending on market conditions and legal requirements.
Amedisys has appointed Ivanetta Davis Samuels to its Board of Directors, effective December 15, 2020. Samuels brings over 25 years of legal expertise from her role as Senior Vice President and General Counsel at Meharry Medical College. Amedisys CEO Paul Kusserow emphasizes her experience will enhance the company's leadership as it seeks to provide quality care for aging patients. Samuels expressed her excitement about joining a board predominantly composed of women and supporting equitable healthcare.
Amedisys, Inc. (NASDAQ: AMED) announced that CEO Paul B. Kusserow will present at the Jefferies Virtual London Healthcare Conference on November 17, 2020, starting at 9:25 a.m. Eastern Time. The presentation will be accessible via live webcast on Amedisys' investor relations website. Amedisys is a leading provider of home health, hospice, and personal care services, serving over 415,000 patients annually through 516 care centers across 39 states and D.C. The company is committed to delivering high-quality healthcare at home.
Amedisys, a leader in home health, hospice, and personal care, announces that CEO Paul B. Kusserow will present at the Stephens Annual Investment Conference on November 19, 2020, at 2:00 p.m. ET. Investors can access the live webcast via the Amedisys website. Founded in 1982 and headquartered in Baton Rouge, LA, Amedisys operates over 500 care centers across 39 states and serves more than 415,000 patients annually, partnering with over 2,600 hospitals and 67,000 physicians nationwide.
Amedisys, Inc. (NASDAQ: AMED), a top provider of home health, hospice, and personal care services, announced that CEO Paul B. Kusserow will present at the 29th Annual Credit Suisse Virtual Healthcare Conference on November 10, 2020, at 2:00 p.m. Eastern Time. The presentation will be available via live webcast on the Amedisys website. Established in 1982 and headquartered in Baton Rouge, LA, Amedisys serves over 415,000 patients annually through its 516 care centers across 39 states and the District of Columbia, employing 21,000 staff dedicated to quality care.
Amedisys, Inc. (NASDAQ: AMED) reported significant growth for Q3 2020, with net service revenue increasing by $49.5 million to $544.1 million compared to Q3 2019. Net income rose to $72.0 million ($2.16 per diluted share), aided by a $0.72 income tax benefit. Year-to-date results also showed a revenue increase of $65.9 million, totaling $1.520 billion, and net income of $138.5 million ($4.16 per diluted share). The company raised its full-year revenue guidance to $2.067-$2.072 billion and adjusted EBITDA forecast to $269-$272 million, asserting strong performance despite COVID-19 challenges.
Amedisys, Inc. (NASDAQ: AMED) will disclose its third-quarter financial results on October 28, 2020, after the market closes. An investor conference call is scheduled for October 29, 2020, at 11:00 a.m. ET to discuss these results. Interested participants can join by calling (877) 524-8416 (Toll-Free) or (412) 902-1028 (Toll). A replay will be available until November 29, 2020. Amedisys offers personalized home health care and hospice services, serving over 415,000 patients annually through more than 21,000 employees across 39 states.
Amedisys, a leading home health, hospice, and personal care company, will have its CEO, Paul B. Kusserow, present at the Baird 2020 Global Healthcare Conference on September 10, 2020, at 1:25 p.m. Eastern Time. Investors can access a live webcast of the presentation through the Amedisys investor relations website. Amedisys, founded in 1982 and headquartered in Baton Rouge, LA, provides personalized care to over 415,000 patients annually through its extensive network of 524 care centers across 39 states.
FAQ
What is the current stock price of Amedisys (AMED)?
What is the market cap of Amedisys (AMED)?
